Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1504 - What measure of treatment effect should be preferred ? A critical review of 20 randomized clinical trials of targeted therapies in chronic lymphocytic leukemia

    Primary Author / Presenter(s)

  • VL

    Vincent Levy, MD, PhD

    head
    Hôpital Avicenne, Département de Recherche Clinique, INSERM U1432, Hôpital Saint Louis
    Bobigny, France

    • Co-Author(s)

  • El

    Etienne lengline, MD

    Hematology Departement, Hôpital Saint Louis, Paris, France
    Paris, Ile-de-France, France

  • SC

    Sylvie Chevret, MD, PhD

    Head
    ECSTRRA team, UMR1342 IRSL, INSERM, Paris Cité University, France
    Paris, Ile-de-France, France